Aging

A tool using long non-coding RNA to better predict outcomes in esophageal squamous cell cancer

Updated

Abstract

An eight-lncRNA signature is associated with a hazard ratio of 3.79 for overall survival in esophageal squamous cell carcinoma patients.

  • The eight-lncRNA signature separates ESCC patients into two groups with significantly different overall survival outcomes.
  • In a validation set, the signature maintains a hazard ratio of 2.73, indicating its prognostic reliability.
  • Cox regression analyses suggest that this signature functions as an independent prognostic factor for ESCC.
  • A nomogram incorporating the lncRNA signature alongside clinical factors shows good accuracy in predicting 1-, 3-, and 5-year survival probabilities.
  • The gene significance for survival time is strongly correlated with the T stage of the cancer.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

CONFLICTS OF INTEREST: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free